Rice Hall James & Associates, LLC Repligen Corp Transaction History
Rice Hall James & Associates, LLC
- $1.53 Billion
- Q1 2025
A detailed history of Rice Hall James & Associates, LLC transactions in Repligen Corp stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 19,449 shares of RGEN stock, worth $2.68 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
19,449
Previous 15,391
26.37%
Holding current value
$2.68 Million
Previous $2.22 Million
11.69%
% of portfolio
0.16%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding RGEN
# of Institutions
480Shares Held
56.5MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$985 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$704 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$233 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$213 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.66B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....